Transarterial Chemoembolization (TACE) Combined with Camrelizumab and Apatinib Versus TACE Alone in the Treatment of Unresectable Hepatocellular Carcinoma Eligible for Embolization: A Multicenter, Open-Label, Randomized, Phase 2 Study (CAP-ACE).
Journal of Clinical Oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要